Association of hormonal contraceptive use with adverse health outcomes: an umbrella review of meta-analyses of randomized clinical trials and cohort studies

S Brabaharan, SK Veettil, JE Kaiser… - JAMA Network …, 2022 - jamanetwork.com
Importance Meta-analyses have reported conflicting data on the safety of hormonal
contraception, but the quality of evidence for the associations between hormonal …

Progestogens with antiandrogenic properties

D Raudrant, T Rabe - Drugs, 2003 - Springer
Chlormadinone acetate, cyproterone acetate and dienogest are potent, orally active
progestogens, which have antiandrogenic instead of partial androgenic activity. They act …

Plasma homocysteine levels and mortality in patients with coronary artery disease

O Nygård, JE Nordrehaug, H Refsum… - … England Journal of …, 1997 - Mass Medical Soc
Background Elevated plasma homocysteine levels are a risk factor for coronary heart
disease, but the prognostic value of homocysteine levels in patients with established …

Prospective study of exogenous hormones and risk of pulmonary embolism in women

F Grodstein, MJ Stampfer, SZ Goldhaber, JAE Manson… - The Lancet, 1996 - thelancet.com
Background Current use of oral contraceptives (OCs) is a well-recognised risk factor for
venous thrombosis and consequent pulmonary embolism (PE). Little is known about …

Oral contraceptive estrogen dose and the risk of deep venous thromboembolic disease

BB Gerstman, JM Piper, DK Tomita… - American journal of …, 1991 - academic.oup.com
Despite the well-recognized association between oral contraceptives and deep venous
thromboembolism, little is known about the risks associated with currently marketed …

Factor VII deficiency.

DJ Perry - British journal of haematology, 2002 - search.ebscohost.com
Review Page 1 Review FACTOR VII DEFICIENCY The rare inherited disorders of coagulation
are a fascinating group of diseases that have provided us with important insights into the …

Bleeding pattern and cycle control with an estradiol-based oral contraceptive: a seven-cycle, randomized comparative trial of estradiol valerate/dienogest and ethinyl …

HJ Ahrendt, D Makalová, S Parke, U Mellinger… - Contraception, 2009 - Elsevier
BACKGROUND: This study compared the bleeding pattern, cycle control and safety of an
oral contraceptive (OC) comprising estradiol valerate/dienogest (E2V/DNG; administered …

Oral contraceptives: a risk factor for uncontrolled blood pressure among hypertensive women

JN Lubianca, CS Faccin - Contraception, 2003 - Elsevier
The objective of the study was to assess the association between systolic and diastolic
blood pressure (SBP and DBP) and the use of oral contraceptives (OC) in hypertensive …

Effects of progestogens on haemostasis

H Kuhl - Maturitas, 1996 - Elsevier
Epidemiological data suggested an involvement of the progestogen component in the
pathomechanism of venous and arterial diseases during intake of oral contraceptives. The …

[HTML][HTML] Impact of progestagens on activated protein C (APC) resistance among users of oral contraceptives

M Alhenc‐Gelas, G Plu‐Bureau, S Guillonneau… - Journal of thrombosis …, 2004 - Elsevier
Oral contraceptive (OC) use is associated with an increased risk of venous
thromboembolism. Previous data reported higher thrombotic risk in women using third …